Effect of atropine 0.01% on myopia control in children aged 6–13 years during the 2022 lockdown in Shanghai

PurposeTo compare the myopic progression in children treated with 0. 01% atropine and those who discontinued atropine during the 2022-home quarantine in Shanghai.MethodsIn this retrospective study, children aged 6–13 years with follow-up visits before (between January 2022 and February 2022) and aft...

Full description

Bibliographic Details
Main Authors: Manrong Yu, Lingli Jiang, Minjie Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2023.1074272/full
_version_ 1797942789276696576
author Manrong Yu
Manrong Yu
Manrong Yu
Manrong Yu
Lingli Jiang
Minjie Chen
Minjie Chen
Minjie Chen
Minjie Chen
author_facet Manrong Yu
Manrong Yu
Manrong Yu
Manrong Yu
Lingli Jiang
Minjie Chen
Minjie Chen
Minjie Chen
Minjie Chen
author_sort Manrong Yu
collection DOAJ
description PurposeTo compare the myopic progression in children treated with 0. 01% atropine and those who discontinued atropine during the 2022-home quarantine in Shanghai.MethodsIn this retrospective study, children aged 6–13 years with follow-up visits before (between January 2022 and February 2022) and after the lockdown (between July 2022 and August 2022) were included. Cycloplegic refraction and axial length (AL) were measured at both visits. The atropine group had continuous medication during the lockdown while the control group discontinued. The 0.01% atropine eyedrops were administered daily before bedtime. The types of spectacle lens were recorded: single vision (SV) spectacles or defocus incorporated multiple segments lenses (DIMS).ResultsIn total, 41 children (81 eyes) in the atropine group and 32 children (64 eyes) in the control group were enrolled. No significant difference was found in the demographic characteristics, spherical diopter, spherical equivalent (SE), AL, and follow-up time between the two groups before the lockdown in 2022 (all p > 0.1). After the home confinement, a greater myopia progression was observed in the control group (−0.46 ± 0.42 D) compared to atropine group (−0.26 ± 0.37 D; p = 0.0023). Axial elongation was also longer in the control group than that in children sustained with atropine (0.21 ± 0.17 vs. 0.13 ± 0.15 mm, p = 0.0035). Moreover, there was no significant change of spherical diopter and SE during lockdown in the atropine + DIMS combined subgroup (0.03 ± 0.033 D for spherical diopter, p = 0.7261 and 0.08 ± 0.27 D for SE, p = 0.2042, respectively). However, significant myopic shift was observed in the atropine + SV subgroup during the quarantine time (−0.31 ± 0.39 D for SE and 0.15 ± 0.16 mm for AL, both p < 0.001).ConclusionChildren treated with 0.01% atropine had slower myopia progression during the lockdown period in Shanghai compared with children discontinued. Moreover, the effect of atropine on myopic prevention can be strengthened with DIMS lenses.
first_indexed 2024-04-10T20:13:08Z
format Article
id doaj.art-1357480cb92c4a1cab376b0d5d0d2209
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-04-10T20:13:08Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-1357480cb92c4a1cab376b0d5d0d22092023-01-26T07:49:19ZengFrontiers Media S.A.Frontiers in Public Health2296-25652023-01-011110.3389/fpubh.2023.10742721074272Effect of atropine 0.01% on myopia control in children aged 6–13 years during the 2022 lockdown in ShanghaiManrong Yu0Manrong Yu1Manrong Yu2Manrong Yu3Lingli Jiang4Minjie Chen5Minjie Chen6Minjie Chen7Minjie Chen8Department of Ophthalmology, Eye and Ear, Nose, and Throat Hospital of Fudan University, Shanghai, ChinaKey Laboratory of Visual Impairment and Restoration of Shanghai, Fudan University, Shanghai, ChinaNHC Key Laboratory of Myopia, Fudan University, Shanghai, ChinaKey Laboratory of Myopia, Chinese Academy of Medical Science, Shanghai, ChinaDepartment of Ophthalmology, The Affiliated Wenling Hospital of Wenzhou Medical University, Wenling, ChinaDepartment of Ophthalmology, Eye and Ear, Nose, and Throat Hospital of Fudan University, Shanghai, ChinaKey Laboratory of Visual Impairment and Restoration of Shanghai, Fudan University, Shanghai, ChinaNHC Key Laboratory of Myopia, Fudan University, Shanghai, ChinaKey Laboratory of Myopia, Chinese Academy of Medical Science, Shanghai, ChinaPurposeTo compare the myopic progression in children treated with 0. 01% atropine and those who discontinued atropine during the 2022-home quarantine in Shanghai.MethodsIn this retrospective study, children aged 6–13 years with follow-up visits before (between January 2022 and February 2022) and after the lockdown (between July 2022 and August 2022) were included. Cycloplegic refraction and axial length (AL) were measured at both visits. The atropine group had continuous medication during the lockdown while the control group discontinued. The 0.01% atropine eyedrops were administered daily before bedtime. The types of spectacle lens were recorded: single vision (SV) spectacles or defocus incorporated multiple segments lenses (DIMS).ResultsIn total, 41 children (81 eyes) in the atropine group and 32 children (64 eyes) in the control group were enrolled. No significant difference was found in the demographic characteristics, spherical diopter, spherical equivalent (SE), AL, and follow-up time between the two groups before the lockdown in 2022 (all p > 0.1). After the home confinement, a greater myopia progression was observed in the control group (−0.46 ± 0.42 D) compared to atropine group (−0.26 ± 0.37 D; p = 0.0023). Axial elongation was also longer in the control group than that in children sustained with atropine (0.21 ± 0.17 vs. 0.13 ± 0.15 mm, p = 0.0035). Moreover, there was no significant change of spherical diopter and SE during lockdown in the atropine + DIMS combined subgroup (0.03 ± 0.033 D for spherical diopter, p = 0.7261 and 0.08 ± 0.27 D for SE, p = 0.2042, respectively). However, significant myopic shift was observed in the atropine + SV subgroup during the quarantine time (−0.31 ± 0.39 D for SE and 0.15 ± 0.16 mm for AL, both p < 0.001).ConclusionChildren treated with 0.01% atropine had slower myopia progression during the lockdown period in Shanghai compared with children discontinued. Moreover, the effect of atropine on myopic prevention can be strengthened with DIMS lenses.https://www.frontiersin.org/articles/10.3389/fpubh.2023.1074272/fullmyopia controlatropineCOVID-19Shanghaimyopia progressionquarantine
spellingShingle Manrong Yu
Manrong Yu
Manrong Yu
Manrong Yu
Lingli Jiang
Minjie Chen
Minjie Chen
Minjie Chen
Minjie Chen
Effect of atropine 0.01% on myopia control in children aged 6–13 years during the 2022 lockdown in Shanghai
Frontiers in Public Health
myopia control
atropine
COVID-19
Shanghai
myopia progression
quarantine
title Effect of atropine 0.01% on myopia control in children aged 6–13 years during the 2022 lockdown in Shanghai
title_full Effect of atropine 0.01% on myopia control in children aged 6–13 years during the 2022 lockdown in Shanghai
title_fullStr Effect of atropine 0.01% on myopia control in children aged 6–13 years during the 2022 lockdown in Shanghai
title_full_unstemmed Effect of atropine 0.01% on myopia control in children aged 6–13 years during the 2022 lockdown in Shanghai
title_short Effect of atropine 0.01% on myopia control in children aged 6–13 years during the 2022 lockdown in Shanghai
title_sort effect of atropine 0 01 on myopia control in children aged 6 13 years during the 2022 lockdown in shanghai
topic myopia control
atropine
COVID-19
Shanghai
myopia progression
quarantine
url https://www.frontiersin.org/articles/10.3389/fpubh.2023.1074272/full
work_keys_str_mv AT manrongyu effectofatropine001onmyopiacontrolinchildrenaged613yearsduringthe2022lockdowninshanghai
AT manrongyu effectofatropine001onmyopiacontrolinchildrenaged613yearsduringthe2022lockdowninshanghai
AT manrongyu effectofatropine001onmyopiacontrolinchildrenaged613yearsduringthe2022lockdowninshanghai
AT manrongyu effectofatropine001onmyopiacontrolinchildrenaged613yearsduringthe2022lockdowninshanghai
AT linglijiang effectofatropine001onmyopiacontrolinchildrenaged613yearsduringthe2022lockdowninshanghai
AT minjiechen effectofatropine001onmyopiacontrolinchildrenaged613yearsduringthe2022lockdowninshanghai
AT minjiechen effectofatropine001onmyopiacontrolinchildrenaged613yearsduringthe2022lockdowninshanghai
AT minjiechen effectofatropine001onmyopiacontrolinchildrenaged613yearsduringthe2022lockdowninshanghai
AT minjiechen effectofatropine001onmyopiacontrolinchildrenaged613yearsduringthe2022lockdowninshanghai